Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
B. Bolstad
Observed names:
B Bolstad,
B. BOLSTAD,
Bjorg Bolstad,
Bjørg Bolstad,
Bjørg J. Bolstad,
Bjørg Johanna Bolstad,
Bolstad, Bjørg Johanna
show all 7
Observed institutions:
Oslo University Hospital,
Karolinska University Hospital,
University of Oslo,
Lund University,
Odense University Hospital,
Direktoratet for medisinske produkter,
Karolinska Institutet,
Nordic Nanovector (Norway),
Stockholm South General Hospital,
Royal Marsden Hospital
show all 10
ORCID:
0009-0007-9064-932X
Observed ORCID:
0009-0007-9064-932X
OpenAlex ID:
A5014460763
Works
36
Awards
5
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
2007
·
Sten Nilsson
, Lars Franzén
, et al.
·
The Lancet Oncology
·
493
Reliability of goniometric measurements and visual estimates of hip ROM in patients with osteoarthrosis
2000
·
Inger Holm
, Bjørg Bolstad
, et al.
·
Physiotherapy Research International
·
164
Overall Survival Benefit of Radium-223 Chloride (Alpharadin™) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)
2011
·
C. Parker
, D. Heinrich
, et al.
·
European Journal of Cancer
·
135
Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
2012
·
Sten Nilsson
, Lars Franzén
, et al.
·
Clinical Genitourinary Cancer
·
115
Five- to 10-Year Prospective Follow-Up of Wrist Arthroplasty in 56 Nonrheumatoid Patients
2017
·
Ole Reigstad
, Trygve Holm-Glad
, et al.
·
The Journal Of Hand Surgery
·
91
Iodixanol and ioxaglate in cardioangiography: A double-blind randomized phase III study
1993
·
P.E. Andersen
, B. Bolstad
, et al.
·
Clinical Radiology
·
55
Promising one- to six-year results with the Motec wrist arthroplasty in patients with post-traumatic osteoarthritis
2012
·
O. Reigstad
, T. Lütken
, et al.
·
Journal of Bone and Joint Surgery - British Volume
·
48
Main Results of the First Comparative Clinical Studies on Visipaque
1995
·
B. H. Grynne
, J. Ø. Nossen
, et al.
·
Acta Radiologica
·
46
Iodixanol in Cardioangiography
1994
·
K. Tveit
, K.-D. Bolz
, et al.
·
Acta Radiologica
·
42
Iodixanol in Cardioangiography: A Double-Blind Parallel Comparison between Iodixanol 320 mg I/ml and Ioxaglate 320 mg I/ml
1994
·
K. Tveit
, K.-D. Bolz
, et al.
·
Acta Radiologica
·
34
Iodixanol in Abdominal Digital Subtraction Angiography: A Randomized, Double-Blind, Parallel Trial with Iodixanol and Iohexol
1993
·
K. Singh
, R. Sundgren
, et al.
·
Acta Radiologica
·
34
Assessment of left ventricular wall motion and delineation of the endocardial border after intravenous injection of InfosonTM during dobutamine stress echocardiography
1998
·
Ignatios lkonomidis
, Emma Holmes
, et al.
·
Coronary Artery Disease
·
33
Safety and Tolerability of Iodixanol: A Dimeric, Nonionic Contrast Medium: An Emphasis on European Clinical Phases I and II
1991
·
B. BOLSTAD
, K. W. BORCH
, et al.
·
Investigative Radiology
·
31
European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis
2019
·
Kyriaki Tzogani
, Yang Yu
, et al.
·
ESMO Open
·
27
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with anFLT3Mutation
2020
·
Kyriaki Tzogani
, Hilde Røshol
, et al.
·
The Oncologist
·
24
PDF
Alkaline phosphatase (ALP) normalization and overall survival in patients with bone metastases from castration-resistant prostate cancer (CRPC) treated with radium-223.
2011
·
C. Parker
, C. G. O'Bryan-Tear
, et al.
·
Journal of Clinical Oncology
·
15
Iodixanol in Femoral Arteriography
1994
·
Ö. Thorstensen
, U. Albrechtsson
, et al.
·
Acta Radiologica
·
15
Iodixanol in Femoral Arteriography: A Randomized, Double-Blind, Phase III, Parallel Study with Iodixanol 270 mg I/ml and Iohexol 300 mg I/ml
1994
·
Ö. Thorstensen
, U. Albrechtsson
, et al.
·
Acta Radiologica
·
12
Radium-223 chloride, a first-in-class alpha-pharmaceutical with a benign safety profile for patients with castration-resistant prostate cancer (CRPC) and bone metastases: Combined analysis of phase I and II clinical trials.
2010
·
S. Nilsson
, C. Parker
, et al.
·
Journal of Clinical Oncology
·
10
Intra-arterial digital subtraction angiography with isotonic dimeric (iodixanol) and monomeric (iohexol) nonionic contrast media: radiographic, clinical and neurophysiological evaluation
1995
·
R. E. M. Hekster
, H. H. E. Morr�
, et al.
·
Neuroradiology
·
9
Supercharging of the ulnar nerve: clinical and neurophysiological assessment at 2 years for nine proximal injuries
2024
·
Rasmus Dehli Thorkildsen
, Inge Petter Kleggetveit
, et al.
·
Journal of Hand Surgery (European Volume)
·
6
European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma
2020
·
Sahra Ali
, Jorge Camarero
, et al.
·
ESMO Open
·
6
A Phase I Study of 177 lu-DOTA-HH1 (Betalutin) Radioimmunotherapy for Patients with Relapsed CD37+ Non-Hodgkin's B Cell Lymphoma
2014
·
Arne Kolstad
, Ulf Madsbu
, et al.
·
Blood
·
4
7018 Alpha-emitting Radium-223: two years follow up from a randomized phase II study in patients with bone metastases from hormone refractory prostate cancer
2009
·
S. Nilsson
, L. Franzen
, et al.
·
European Journal of Cancer Supplements
·
4
Alpharadin, a novel, highly targeted alpha pharmaceutical with a good safety profile for patients with CRPC and bone metastases: Combined safety analyses of phase I and II clinical trials
2009
·
Stefan Nilsson
, Charles Parker
, et al.
·
3
Show more works
View as search
Works count:
36
Citation count:
1,463
H-index:
15
I10-index:
19
Year
Topic
Type
